Dako, a Danish-based world leader in tissue-based cancer diagnostics, and Omnyx, a leader in digital pathology solutions, announced today that they have entered into a three-year agreement to develop clinical algorithms for digital pathology.
40577
Dako, Omnyx partner to develop clinical algorithms for digital pathology
84051
Plexxikon initiates Phase 1 trial for PLX5568
137699
3D breakthrough in growing organs
28320
Incyte enters into collaboration and license agreement with Novartis
120225
Medseek acquires Third Wave Research
36383
Rcf announces digital matrix mixers
59176
Molex assigned patent for patch panel assembly for use with data networks
30101
Advaxis receives Research coverage
118720
Telemedicus joins BioHouston
108236
Abbott licenses biomarkers for use in differentiating aggressive from nonaggressive prostate cancer
17376
Universal Detection Technology signs distribution agreement with
124765
Indentec increases accreditation for calibration of Vickers and Knoop test blocks
71566
Hologic agrees to buy Gen-Probe for about $3.72 billion
151825
Toward stem cell pharmacies
126233
Astex achieves milestones in drug discovery collaboration
149878
Shikatronics joins in the fight against Breast Cancer
119181
Tissue Regenix narrows losses